ARDS

FDA rejects Covid-19 drug over uncertainties around small trial
FDA rejects Covid-19 drug over uncertainties around small trial
Endpoints
Veru
clinical trials
COVID-19
ARDS
sabizabulin
Flag link:
Incyte Drug Misses Endpoint in COVID-Respiratory-Distress Trial
Incyte Drug Misses Endpoint in COVID-Respiratory-Distress Trial
TheStreet.com
Incyte
Jakafi
clinical trials
COVID-19
ARDS
Flag link:
Novartis Inks $1.35 Billion Deal with Mesoblast for Remestemcel-L for COVID-19 ARDS
Novartis Inks $1.35 Billion Deal with Mesoblast for Remestemcel-L for COVID-19 ARDS
BioSpace
Novartis
Mesoblast
remestemcel-L
COVID-19
ARDS
clinical trials
Flag link:
Stem Cells May Help COVID-19 and ARDS Patients Breathe Easier
Stem Cells May Help COVID-19 and ARDS Patients Breathe Easier
BioSpace
COVID-19
ARDS
Athersys
stem cells
Flag link:
FDA accepts Enzychem’s IND for trial of Covid-19 treatment candidate
FDA accepts Enzychem’s IND for trial of Covid-19 treatment candidate
Pharmaceutical Business Review
Enzychem Lifesciences
FDA
EC-18
ARDS
COVID-19
COVID-19 pneumonia
Flag link:
Clinical Trials Of Mesoblast’s Stem Cell Treatment For COVID-19 Set To Begin Soon
Clinical Trials Of Mesoblast’s Stem Cell Treatment For COVID-19 Set To Begin Soon
Forbes
Mesoblast
Australia
clinical gtrials
ARDS
COVID-19
stem cells
remestemcel-L
Flag link:
Preliminary Data from Pluristem’s PLC Cell Program Shows Promise in COVID-19
Preliminary Data from Pluristem’s PLC Cell Program Shows Promise in COVID-19
BioSpace
COVID-19
Pluristem Therapeutics
PLC cell program
ARDS
Flag link:
Citius, Novellus collaborate on novel stem-cell therapy for ARDS associated with COVID-19
Citius, Novellus collaborate on novel stem-cell therapy for ARDS associated with COVID-19
Pharmaceutical Business Review
Citius Pharmaceuticals
Novelius
stem cells
ARDS
COVID-19
Flag link:
Here's Why Athersys Is Soaring Today
Here's Why Athersys Is Soaring Today
Motley Fool
Athersys
Japan
clinical trials
stem cells
MultiStem
ARDS
Flag link:
Faron Pharmaceuticals Drug Traumakine Fails Ph III Trial
Faron Pharmaceuticals Drug Traumakine Fails Ph III Trial
CP Wire
Faron Pharmaceuticals
clinical trials
Traumakine
ARDS
Flag link:
Why Questcor's Latest Clinical Study is a Big Deal
Why Questcor's Latest Clinical Study is a Big Deal
Motley Fool
Questcor
ARDS
H.P. Acthar Gel
Flag link: